CN100457098C - 甲磺酸萘莫司他冻干粉针剂及其制备方法 - Google Patents
甲磺酸萘莫司他冻干粉针剂及其制备方法 Download PDFInfo
- Publication number
- CN100457098C CN100457098C CNB200610161308XA CN200610161308A CN100457098C CN 100457098 C CN100457098 C CN 100457098C CN B200610161308X A CNB200610161308X A CN B200610161308XA CN 200610161308 A CN200610161308 A CN 200610161308A CN 100457098 C CN100457098 C CN 100457098C
- Authority
- CN
- China
- Prior art keywords
- nafamostat
- injection
- nafamostat mesilate
- add
- value
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200610161308XA CN100457098C (zh) | 2006-12-20 | 2006-12-20 | 甲磺酸萘莫司他冻干粉针剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200610161308XA CN100457098C (zh) | 2006-12-20 | 2006-12-20 | 甲磺酸萘莫司他冻干粉针剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN100998580A CN100998580A (zh) | 2007-07-18 |
CN100457098C true CN100457098C (zh) | 2009-02-04 |
Family
ID=38257451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200610161308XA Active CN100457098C (zh) | 2006-12-20 | 2006-12-20 | 甲磺酸萘莫司他冻干粉针剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100457098C (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4267125A4 (en) * | 2020-12-22 | 2024-06-26 | Ege Universitesi | DEVELOPMENT OF AN INNOVATIVE INHALATION FORMULATION OF NAFAMOSTAT MESYLATE FOR THE MANAGEMENT OF COVID-19 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102836132A (zh) * | 2012-04-09 | 2012-12-26 | 珠海亿邦制药股份有限公司 | 一种甲磺酸萘莫司他冻干粉针剂 |
CN102743371A (zh) * | 2012-07-26 | 2012-10-24 | 山东省眼科研究所 | 一种治疗视网膜新生血管性疾病的药物 |
CN105412060B (zh) * | 2015-11-15 | 2018-06-08 | 北京泰德制药股份有限公司 | 一种甲磺酸萘莫司他组合物及其制备方法 |
CN105363017A (zh) * | 2015-11-15 | 2016-03-02 | 北京泰德制药股份有限公司 | 一种含有多粘菌素b的组合物及其制备方法 |
US10052315B2 (en) * | 2016-01-08 | 2018-08-21 | Celgene Corporation | Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001163776A (ja) * | 1999-09-30 | 2001-06-19 | Nisshin Oil Mills Ltd:The | 安定化された液剤 |
JP2003089632A (ja) * | 2001-09-17 | 2003-03-28 | Otsuka Pharmaceut Factory Inc | 注射用水性製剤 |
-
2006
- 2006-12-20 CN CNB200610161308XA patent/CN100457098C/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001163776A (ja) * | 1999-09-30 | 2001-06-19 | Nisshin Oil Mills Ltd:The | 安定化された液剤 |
JP2003089632A (ja) * | 2001-09-17 | 2003-03-28 | Otsuka Pharmaceut Factory Inc | 注射用水性製剤 |
Non-Patent Citations (2)
Title |
---|
药用辅料应用技术. 侯惠民等,28,中国医药科技出版社. 2002 |
药用辅料应用技术. 侯惠民等,28,中国医药科技出版社. 2002 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4267125A4 (en) * | 2020-12-22 | 2024-06-26 | Ege Universitesi | DEVELOPMENT OF AN INNOVATIVE INHALATION FORMULATION OF NAFAMOSTAT MESYLATE FOR THE MANAGEMENT OF COVID-19 |
Also Published As
Publication number | Publication date |
---|---|
CN100998580A (zh) | 2007-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6346162B2 (ja) | アリールスルファターゼaのcns送達の方法および組成物 | |
EP0649659B1 (en) | Rapamycin formulation for IV injection | |
CN100457098C (zh) | 甲磺酸萘莫司他冻干粉针剂及其制备方法 | |
JP6045493B2 (ja) | アリールスルファターゼaのcns送達の方法および組成物 | |
NO175287B (no) | Fremgangsmåte for fremstilling av et intravenöst, farmasöytisk preparat | |
CN101283986A (zh) | 一种奥美拉唑钠冻干粉针剂及制备方法 | |
CN102166186A (zh) | 一种更加稳定的氮杂环己肽类制剂 | |
CN101129368B (zh) | 含有兰索拉唑的冻干粉针 | |
AU2002327307B2 (en) | Clathrates of butylphtualide with cyclodextrin or its derivatives, a process for their preparations and the use there of | |
CN102512379B (zh) | 一种新型棘白菌素类抗真菌药物组合物及其制备方法 | |
JPH07502544A (ja) | 眼内組織潅注用および眼内外科処置中の瞳孔散大維持用組成物 | |
CN101874789B (zh) | 含有兰索拉唑的冻干粉针 | |
CN102210686A (zh) | 一种含更昔洛韦化合物的药物组合物及其制备方法 | |
CN101953807A (zh) | 一种注射用吗替麦考酚酯冻干粉针剂及其制备方法 | |
CN105769756B (zh) | 一种富马酸西他沙星注射剂及其制备方法 | |
CN106860446A (zh) | 小儿复方氨基酸注射液19aa‑i 组合物及降低其氧含量的方法 | |
CN102166200A (zh) | 一种含猪脑蛋白水解物的冻干组合物及其制备方法 | |
CN109078001A (zh) | 一种新型万古霉素纳米脂质体组合物及其制备方法 | |
CN103040737A (zh) | 一种含有兰索拉唑化合物的药物组合物及其制备方法 | |
CN102274194A (zh) | 一种含托烷司琼化合物的药物组合物及其制备方法 | |
CN109381435B (zh) | 一种右旋兰索拉唑冻干粉针剂、其制备方法及应用 | |
CN107281118A (zh) | 一种稳定性好的左旋奥拉西坦冻干粉针及其制备方法 | |
CN105363017A (zh) | 一种含有多粘菌素b的组合物及其制备方法 | |
CN103271879A (zh) | 一种稳定的果糖组合物及其制备方法 | |
CN100356912C (zh) | 一种硫普罗宁冻干制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: LANZHOU JINGLONG MEDICAL TECHNOLOGY CO., LTD. Effective date: 20120410 Owner name: JIANGSU D+R PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: NANJING KEYUAN MEDICINAL TECHNOLOGY CO., LTD. Effective date: 20120410 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 210009 NANJING, JIANGSU PROVINCE TO: 225300 TAIZHOU, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120410 Address after: 225300, G38, 1 drug City Avenue, Jiangsu, Taizhou Patentee after: JIANGSU D&R PHARMACEUTICAL CO., LTD. Address before: 210009 139 Ma Tai Street, Jiangsu, Nanjing 410 Co-patentee before: Lanzhou Jinglong Medical Technology Co., Ltd. Patentee before: Nanjing Keyuan Medicinal Technology Co., Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Nafolimus mesylate lyophilized powder injection and its preparation method Effective date of registration: 20220104 Granted publication date: 20090204 Pledgee: Bank of Nanjing Co.,Ltd. Taizhou high tech Zone sub branch Pledgor: JIANGSU D&R PHARMACEUTICAL Co.,Ltd. Registration number: Y2021980017400 |